ARTICLE | Clinical News
Novavax Inc preclinical data
April 13, 2015 7:00 AM UTC
In non-human primates, 2 injections of 5 ug EBOV GP vaccine plus the company’s Matrix M adjuvant protected animals from a lethal challenge with Ebola virus for 18 days post-challenge whereas the chal...